PURPOSE: The aim of the present study was to determine whether preoperative cerebrovascular reactivity (CVR) to acetazolamide measured by quantitative brain perfusion single-photon emission computed tomography (SPECT) predicts development of cerebral ischemic lesions on postoperative diffusion-weighted magnetic resonance imaging (DWI) that are caused by microemboli during carotid endarterectomy (CEA). MATERIALS AND METHODS: One hundred and fifty patients with ipsilateral internal carotid artery stenosis (>70%) underwent CEA under transcranial Doppler monitoring of microembolic signals (MES) in the ipsilateral middle cerebral artery (MCA). Preoperative CVR to acetazolamide was measured using [(123)I]N-isopropyl-p-iodoamphetamine SPECT, and region of interest (ROI) analysis in the ipsilateral MCA territory was performed using a three-dimensional stereotaxic ROI template. DWI was performed within 3 days before and 24 h after surgery. RESULTS: Twenty-six patients (17.3%) developed new postoperative ischemic lesions on DWI. Logistic regression analysis demonstrated that, among the variables tested, a high number of MES during carotid dissection (95% CIs, 1.179 to 1.486; P < 0.0001) and preoperative reduced CVR to acetazolamide (95% CIs, 0.902 to 0.974; P = 0.0008), which were significantly associated with the development of new postoperative ischemic lesions on DWI. In 47 patients with MES during carotid dissection, the combination of number of MES during carotid dissection and CVR to acetazolamide identified development of new postoperative ischemic lesions on DWI with a positive predictive value of 100% or zero. CONCLUSIONS: Preoperative CVR to acetazolamide measured by quantitative brain perfusion SPECT predicts development of cerebral ischemic lesions on postoperative DWI that are caused by microemboli during CEA.
PURPOSE: The aim of the present study was to determine whether preoperative cerebrovascular reactivity (CVR) to acetazolamide measured by quantitative brain perfusion single-photon emission computed tomography (SPECT) predicts development of cerebral ischemic lesions on postoperative diffusion-weighted magnetic resonance imaging (DWI) that are caused by microemboli during carotid endarterectomy (CEA). MATERIALS AND METHODS: One hundred and fifty patients with ipsilateral internal carotid artery stenosis (>70%) underwent CEA under transcranial Doppler monitoring of microembolic signals (MES) in the ipsilateral middle cerebral artery (MCA). Preoperative CVR to acetazolamide was measured using [(123)I]N-isopropyl-p-iodoamphetamine SPECT, and region of interest (ROI) analysis in the ipsilateral MCA territory was performed using a three-dimensional stereotaxic ROI template. DWI was performed within 3 days before and 24 h after surgery. RESULTS: Twenty-six patients (17.3%) developed new postoperative ischemic lesions on DWI. Logistic regression analysis demonstrated that, among the variables tested, a high number of MES during carotid dissection (95% CIs, 1.179 to 1.486; P < 0.0001) and preoperative reduced CVR to acetazolamide (95% CIs, 0.902 to 0.974; P = 0.0008), which were significantly associated with the development of new postoperative ischemic lesions on DWI. In 47 patients with MES during carotid dissection, the combination of number of MES during carotid dissection and CVR to acetazolamide identified development of new postoperative ischemic lesions on DWI with a positive predictive value of 100% or zero. CONCLUSIONS: Preoperative CVR to acetazolamide measured by quantitative brain perfusion SPECT predicts development of cerebral ischemic lesions on postoperative DWI that are caused by microemboli during CEA.
Authors: B A N Verhoeven; J P P M de Vries; G Pasterkamp; R G A Ackerstaff; A H Schoneveld; E Velema; D P V de Kleijn; F L Moll Journal: Stroke Date: 2005-07-07 Impact factor: 7.914
Authors: M E Gaunt; P J Martin; J L Smith; T Rimmer; G Cherryman; D A Ratliff; P R Bell; A R Naylor Journal: Br J Surg Date: 1994-10 Impact factor: 6.939
Authors: R G Ackerstaff; K G Moons; C J van de Vlasakker; F L Moll; F E Vermeulen; A Algra; M P Spencer Journal: Stroke Date: 2000-08 Impact factor: 7.914
Authors: J H Kim; S J Lee; T Shin; K H Kang; P Y Choi; J H Kim; J C Gong; N C Choi; B H Lim Journal: AJNR Am J Neuroradiol Date: 2000-09 Impact factor: 3.825
Authors: Ozlem L Kapucu; Flavio Nobili; Andrea Varrone; Jan Booij; Thierry Vander Borght; Kjell Någren; Jacques Darcourt; Klaus Tatsch; Koen J Van Laere Journal: Eur J Nucl Med Mol Imaging Date: 2009-12 Impact factor: 9.236
Authors: Molly G Bright; Manus J Donahue; Jeff H Duyn; Peter Jezzard; Daniel P Bulte Journal: J Cereb Blood Flow Metab Date: 2010-10-20 Impact factor: 6.200
Authors: S Yamashita; M Kohta; K Hosoda; J Tanaka; K Matsuo; H Kimura; K Tanaka; A Fujita; T Sasayama Journal: AJNR Am J Neuroradiol Date: 2022-07-14 Impact factor: 4.966
Authors: Y Sato; K Ogasawara; S Narumi; M Sasaki; A Saito; E Tsushima; T Namba; M Kobayashi; K Yoshida; Y Terayama; A Ogawa Journal: AJNR Am J Neuroradiol Date: 2016-02-04 Impact factor: 3.825
Authors: Renata F Leoni; Kelley C Mazzetto-Betti; Afonso C Silva; Antonio C Dos Santos; Draulio B de Araujo; João P Leite; Octavio M Pontes-Neto Journal: Radiol Res Pract Date: 2012-06-20